Detail akcie Neogen Corp online

Business Summary: Neogen Corporation is engaged in developing, manufacturing and marketing a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. Its Food Safety segment consists primarily of diagnostic test kits and complementary products sold to food producers and processors to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues and general sanitation concerns. The Company’s Animal Safety segment is engaged in the development, manufacture, marketing, and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services for the worldwide animal safety market.
Financial Summary: BRIEF: For the fiscal year ended 31 May 2024, Neogen Corp revenues increased 12% to $924.2M. Net loss decreased 59% to $9.4M. Revenues reflect Food Safety segment increase of 20% to $655.3M, International segment increase of 15% to $459M, Domestic segment increase of 10% to $465.2M. Lower net loss reflects Food Safety segment income increase of 36% to $82.4M, Corporate and Eliminations segment loss decrease of 5% to $63.1M.